Carisoprodol Tablet
Product Images NDC 72789-182

Product Visual Gallery

This gallery contains 2 technical images submitted to the FDA as part of the official labeling for Carisoprodol (NDC 72789-182). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Pd-rx Pharmaceuticals, Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

72789182 Label (72789182)

The label for Carisoprodol Tablets USP shows a strength of 350 mg, with 100 tablets per package. It is an oral tablet marketed and packaged by PD-Rx Pharmaceuticals, Inc., Oklahoma City, OK, and manufactured by Oxford Pharmaceuticals, Birmingham, Alabama. The label includes storage instructions, a barcode, and notes that the product is prescription only (Rx Only) and schedule IV controlled substance.*

FDA Label Image

Structural Formula (Structure)

Chemical structure of Carisoprodol shown as a molecular diagram depicting its arrangement of atoms and chemical bonds.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.